FDA Grants HSB-1216 Orphan Drug Designation for Small Cell Lung CancerHillstream BioPharma announced that it has been granted FDA orphan drug designation (ODD) for HSB-1216 for the treatment of small cell lung cancer (SCLC).1-2 QUATRAMER salinomycin is a new formulation... By Editorial Team2 min readBookmark for laterReactions 0 reactions Comments0 comments
Take The Clinical Trial Patient Voice Survey (Now Closed)Have you participated in a clinical trial? Are you interested in participating in future clinical trials? We want to hear more about your experience! LungCancer.net/Health Union is teaming up with... By Editorial Team1 min readBookmark for laterReactions 0 reactions Comments0 comments
Research Shows Cancer Likely to Become More Deadly than Heart DiseaseHeart disease is the leading cause of death in Americans, but new research shows that cancer is likely to surpass heart disease as the number one killer in 2020, especially... By Emily Downward2 min readBookmark for laterReactions 0 reactions Comments1 comments
Newly Approved Test Can Detect Multiple Genetic Mutations in CancerThe U.S. Food and Drug Administration (FDA) has approved a new genetic test that can detect 324 different genes that are known to be involved in 5 different cancer types:... By Emily Downward2 min readBookmark for laterReactions 0 reactions Comments0 comments
Calling All Lung Cancer Advocates!November is our month. If you have been impacted in any way by lung cancer, this is your calling to take action. This is your opportunity to take a stand... By Dusty Donaldson2 min readBookmark for laterReactions 0 reactions Comments0 comments
New Biosimilar for the Treatment of Lung Cancer ApprovedThe U.S. Food and Drug Administration (FDA) has approved the first biosimilar for the treatment of cancer: Mvasi™ (bevacizumab-awwb). Mvasi is a biosimilar to Avastin® (bevacizumab) and like Avastin, it... By Emily Downward3 min readBookmark for laterReactions 0 reactions Comments0 comments
New Tools & Features on LungCancer.netYou may have noticed some changes around lungcancer.net. We’re thrilled to announce that we’ve added some new features and functionality to provide an even better experience for the most important... By Editorial Team1 min readBookmark for laterReactions 0 reactions Comments0 comments
